|
⚲
|
| Keyboard |
| Puissance Capital Management LP
✚
|
|
|---|---|
| CRD # | 175226 |
| SEC # | 801-135328 |
| CIK # | 0001658437 |
| AUM | 45.0 M (2026-01-13) |
| Employees | 2 (50% Investors, 50% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-878-3702 |
| Address | |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Scynexis Inc | 1.4 | ||
| Corvus Pharmaceuticals Inc | 0.2 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | PCM AI Opportunities Fund | [2019-03-14] | 1.0 M | 12.0 M |
| Filed 2025-10-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Puissance Cross-Border Opportunities III LLC | 2018-01-25 | 3.0 M | |
| PE | Puissance Cross-Border Opportunities II LLC | 2018-01-25 | 8.3 M | |
| PE | Puissance Cross-Border Opportunities IV LLC | 2018-01-25 | 2.0 M | |
| PE | Puissance Cross Border Opportunities V LLC | 2018-01-25 | 0.2 M | |
| PE | Puissance Life Science Opportunities Fund VII | 2018-01-25 | 0.0 M | |
| HF | Puissance China Market Neutral Master Fund LP | [2017-03-30] | 44.8 M | 1.9 M |
| Filed 2016-03-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Puissance Cross-Border Opportunities I LP | 2017-03-30 | 31.2 M | |
| HF | Puissance Asia Master Fund LP | [2015-07-09] | 10.0 M | 8.5 M |
| Filed 2015-06-02 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Puissance Capital Master Fund LP | [2015-07-09] | 44.8 M | 80.7 M |
| Filed 2016-03-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 33.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 1 | 12.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 45.0 |
| By Discretionary | ||
| Discretionary | 3 | 45.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 45.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 45.0 | |
| United States Persons | 0.0 | |
| Total | 3 | 45.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ted Wang | Director, Executive Officer | 19 | 3 | |
| Puissance Capital Fund GP LLC | Executive Officer | 2 | 1 | |
| Puissance Capital Management LP | Executive Officer | 2 | 1 | |
| Hanchen Jin | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001658437] | |
| 3 | [0001658437] | |
| 4 | [0001658437] | |
| SC 13D | [0001658437] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Puissance Capital Management LP | ViewRay Inc | [2017-01-25] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 254900XD1KV0Z9RJYC26 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2023-10-13 | Sell | 1,076,841 | $0.10 | 107,684 |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2023-06-07 | Sell | 134,421 | $0.83 | 111,569 |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2023-05-18 | Sell | 560,000 | $9.46 | 5,297,600 |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2021-06-07 | Grant | 8,189 | $4.00 | 32,756 |
|
Bellerophon Therapeutics Inc BLPH
Warrants (Right to buy) · derivative
|
2021-04-26 | Grant | 380,950 | $0.00 | |
|
Bellerophon Therapeutics Inc BLPH
Warrants (Right to buy) · derivative
|
2021-04-26 | Grant | 304,286 | $0.00 | |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2021-04-26 | Grant | 609,231 | $4.00 | 2,436,924 |
|
ChronoScale Holdings Corp EKSO
Common Stock
|
2020-07-23 | Grant | 7,383 | $0.00 | |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2020-05-21 | Grant | 1,153,846 | $13.00 | 14,999,998 |
|
Bellerophon Therapeutics Inc BLPH
Common Stock
|
2020-04-17 | Other | 553,250 | ||
|
ChronoScale Holdings Corp EKSO
Common Stock
|
2020-03-02 | Other | 8,918,898 | ||
|
ChronoScale Holdings Corp EKSO
Stock Option (right to buy) · derivative
|
2020-01-16 | Grant | 136,496 | $0.00 | |
|
ChronoScale Holdings Corp EKSO
Common Stock
|
2020-01-16 | Grant | 19,445 | $0.45 | 8,750 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2019-12-09 | Sell | 340,134 | $2.92 | 993,191 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2019-12-05 | Sell | 43,996 | $3.05 | 134,188 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2018-11-29 | Buy | 4,326 | $1.13 | 4,888 |
|
Tracon Pharmaceuticals Inc TCON
Common Stock
|
2018-11-29 | Sell | 4,326 | $1.21 | 5,234 |
|
ChronoScale Holdings Corp EKSO
Common Stock
|
2018-08-03 | Grant | 19,179 | $1.79 | 34,330 |
|
ChronoScale Holdings Corp EKSO
Employee Stock Option (right to buy) · derivative
|
2018-08-03 | Grant | 41,000 | $0.00 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Altai Capital Management LP
✚
|
49.8 M | |
|
BRS Financial LLC
✚
|
AR | |
|
Kitano Capital LLC
✚
|
TX | |
|
Fortius Financial Advisors LLC
✚
|
UT | |
|
Westcliff Capital Management LLC
✚
|
CA | |
|
Hudson Park Management LLC
✚
|
NY | |
|
CH Investment Partners LLC
✚
|
TX | |
|
Income Partners Asset Management HK Limited
✚
|
||
|
Schmidt Advisory Services Inc
✚
|
IL | |
|
Edge Capital Group LLC
✚
|
GA |